Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J. Kuter, Janet L. Nichol, James B. Bussel et al.|The Lancet|2008Cited by 862
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous ThromboembolismPaul M. Ridker, Robert J. Glynn, Steven R. Deitcher et al.|New England Journal of Medicine|2003Cited by 809
Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI TrialValery T. Miller, Sally A. Shumaker, John C. LaRosa et al.|JAMA|1995Cited by 605
A Prospective Study of Human Immunodeficiency Virus Type 1 Infection and the Development of AIDS in Subjects with HemophiliaJames J. Goedert, Mitchell H. Gail, Craig M. Kessler et al.|New England Journal of Medicine|1989Cited by 528
End-stage liver disease in persons with hemophilia and transfusion-associated infections.James J. Goedert, Angelos Hatzakis, M. Elaine Eyster et al.|PubMed|2002Cited by 165